|
1
|
Miszczyk L, Maciejewski B, Tukiendorf A,
Woźniak G, Jochymek B, Gawryszuk A and Szweda M: Split-course
accelerated hyperfractionated irradiation (CHA-CHA) as a sole
treatment for advanced head and neck cancer patients-final results
of a randomized clinical trial. Br J Radiol. 87:201402122014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ghai B, Jain K, Bansal D and Bhatia N:
End-tidal sevoflurane concentration for ProSeal™ versus Classic™
laryngeal mask airway insertion in unpremedicated anaesthetised
adult females. Anaesth Intensive Care. 44:221–226. 2016.PubMed/NCBI
|
|
3
|
Takácsi-Nagy Z, Hitre E, Remenár É, Oberna
F, Polgár C, Major T, Gödény M, Fodor J and Kásler M: Docetaxel,
cisplatin and 5-fluorouracil induction chemotherapy followed by
chemoradiotherapy or chemoradiotherapy alone in stage III–IV
unresectable head and neck cancer: Results of a randomized phase II
study. Strahlenther Onkol. 191:635–641. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Janoray G, Pointreau Y, Garaud P, Chapet
S, Alfonsi M, Sire C, Jadaud E and Calais G: Long-term results of a
multicenter randomized phase III trial of induction chemotherapy
with cisplatin, 5-fluorouracil, ± docetaxel for larynx
preservation. J Natl Cancer Inst. 108:pii: djv368. 2015.PubMed/NCBI
|
|
5
|
Yu X and Li Z: The role of microRNAs
expression in laryngeal cancer. Oncotarget. 6:23297–23305. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang CX, Zhu Y, Duan GL, Yao JF, Li ZY,
Li D and Wang QQ: Screening for miRNAs related to laryngeal
squamous carcinoma stem cell radiation. Asian Pac J Cancer Prev.
14:4533–4537. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li JZ, Gao W, Lei WB, Zhao J, Chan JY, Wei
WI, Ho WK and Wong TS: MicroRNA 744-3p promotes MMP-9-mediated
metastasis by simultaneously suppressing PDCD4 and PTEN in
laryngeal squamous cell carcinoma. Oncotarget. 7:58218–58233. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang X, Xiao D, Wang Z, Zou Y, Huang L,
Lin W, Deng Q, Pan H, Zhou J, Liang C, et al: MicroRNA-26a/b
regulate DNA replication licensing, tumorigenesis, and prognosis by
targeting CDC6 in lung cancer. Mol Cancer Res. 12:1535–1546. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Z, Kim K, Li X, Moreno M, Sharp T,
Goodheart MJ, Safe S, Dupuy AJ and Amendt BA: MicroRNA-26b
represses colon cancer cell proliferation by inhibiting lymphoid
enhancer factor 1 expression. Mol Cancer Ther. 13:1942–1951. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin C, Wang Z, Li L, He Y, Fan J, Liu Z,
Zhao S and Ju D: The role of autophagy in the cytotoxicity induced
by recombinant human arginase in laryngeal squamous cell carcinoma.
Appl Microbiol Biotechnol. 99:8487–8494. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pereira DL, Dos Santos Ferreira AC, de
Faria GP and Kwee JK: Autophagy interplays with apoptosis and cell
cycle regulation in the growth inhibiting effect of Trisenox in
HEP-2, a laryngeal squamous cancer. Pathol Oncol Res. 21:103–111.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li R, Tan S, Yu M, Jundt MC, Zhang S and
Wu M: Annexin A2 regulates autophagy in Pseudomonas
aeruginosa infection through the Akt1-mTOR-ULK1/2 signaling
pathway. J Immunol. 195:3901–3911. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Miki Y, Tanji K, Mori F, Utsumi J, Sasaki
H, Kakita A, Takahashi H and Wakabayashi K: Alteration of upstream
autophagy-related proteins (ULK1, ULK2, Beclin1, VPS34 and AMBRA1)
in Lewy body disease. Brain Pathol. 26:359–370. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shukla S, Patric IR, Patil V, Shwetha SD,
Hegde AS, Chandramouli BA, Arivazhagan A, Santosh V and
Somasundaram K: Methylation silencing of ULK2, an autophagy gene,
is essential for astrocyte transformation and tumor growth. J Biol
Chem. 289:22306–22318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Snietura M, Jaworska M, Mlynarczyk-Liszka
J, Goraj-Zajac A, Piglowski W, Lange D, Wozniak G, Nowara E and
Suwinski R: PTEN as a prognostic and predictive marker in
postoperative radiotherapy for squamous cell cancer of the head and
neck. PLoS One. 7:e333962012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang JQ, Liang Z, Wu M, Sun YM and Liu HX:
Expression of p27 and PTEN and clinical characteristics in early
laryngeal squamous cell carcinoma and their correlation with
recurrence. Int J Clin Exp Pathol. 8:5715–5720. 2015.PubMed/NCBI
|
|
17
|
Guo Q and Li Y: Research on the expression
of Survivin and PTEN in laryngeal squamous cell carcinoma
transplanted on the back sides of nude mice treated by gold throat
tablets. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi.
26:1134–1137, 1143. 2012.(In Chinese). PubMed/NCBI
|
|
18
|
Yang N, Hui L, Wang Y, Yang H and Jiang X:
SOX2 promotes the migration and invasion of laryngeal cancer cells
by induction of MMP-2 via the PI3K/Akt/mTOR pathway. Oncol Rep.
31:2651–2659. 2014.PubMed/NCBI
|
|
19
|
García-Carracedo D, Villaronga MA,
Álvarez-Teijeiro S, Hermida-Prado F, Santamaría I, Allonca E,
Suárez-Fernández L, Gonzalez MV, Balbín M, Astudillo A, et al:
Impact of PI3K/AKT/mTOR pathway activation on the prognosis of
patients with head and neck squamous cell carcinomas. Oncotarget.
7:29780–29793. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bao YY, Zhou SH, Lu ZJ, Fan J and Huang
YP: Inhibiting GLUT-1 expression and PI3K/Akt signaling using
apigenin improves the radiosensitivity of laryngeal carcinoma in
vivo. Oncol Rep. 34:1805–1814. 2015.PubMed/NCBI
|
|
21
|
Wang J, Zhao X, Pan X, Zhao L, Zhou J and
Ji M: The role of primary surgical treatment in young patients with
squamous cell carcinoma of the larynx: A 20-year review of 34
cases. World J Surg Oncol. 13:2832015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhong JT and Zhou SH: Warburg effect,
hexokinase-II, and radioresistance of laryngeal carcinoma.
Oncotarget. 8:14133–14146. 2017.PubMed/NCBI
|
|
23
|
Yoo GH, Moon J, Leblanc M, Lonardo F, Urba
S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J, et al: A phase 2
trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene
therapy followed by chemoradiotherapy for advanced, resectable
squamous cell carcinoma of the oral cavity, oropharynx,
hypopharynx, and larynx: Report of the Southwest Oncology Group.
Arch Otolaryngol Head Neck Surg. 135:869–874. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mirisola V, Mora R, Esposito AI, Guastini
L, Tabacchiera F, Paleari L, Amaro A, Angelini G, Dellepiane M,
Pfeffer U, et al: A prognostic multigene classifier for squamous
cell carcinomas of the larynx. Cancer Lett. 307:37–46. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao S, Wang J, Xie J, Zhang T and Dong P:
Role of miR-138 in the regulation of larynx carcinoma cell
metastases. Tumour Biol. 2015.
|
|
26
|
Espinoza-Mellado MR, Reyes-Picaso C,
Garcés-Pérez MS, Jardón-Serrano CV, López-Villegas EO and
Giono-Cerezo S: Haemophilus influenzae triggers autophagy in
HEp-2 cells. Arch Microbiol. 198:199–204. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yuan P, Cao W, Zang Q, Li G, Guo X and Fan
J: The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance
of hepatocellular carcinoma cells via modulating autophagy. Biochem
Biophys Res Commun. 478:1067–1073. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chan EY, Kir S and Tooze SA: siRNA
screening of the kinome identifies ULK1 as a multidomain modulator
of autophagy. J Biol Chem. 282:25464–25474. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Clotaire DZ John, Zhang B, Wei N, Gao R,
Zhao F, Wang Y, Lei M and Huang W: MiR-26b inhibits autophagy by
targeting ULK2 in prostate cancer cells. Biochem Biophys Res
Commun. 472:194–200. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jung CH, Jun CB, Ro SH, Kim YM, Otto NM,
Cao J, Kundu M and Kim DH: ULK-Atg13-FIP200 complexes mediate mTOR
signaling to the autophagy machinery. Mol Biol Cell. 20:1992–2003.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Phadngam S, Castiglioni A, Ferraresi A,
Morani F, Follo C and Isidoro C: PTEN dephosphorylates AKT to
prevent the expression of GLUT1 on plasmamembrane and to limit
glucose consumption in cancer cells. Oncotarget. 7:84999–85020.
2016.PubMed/NCBI
|
|
32
|
Kan X, Sun Y, Lu J, Li M, Wang Y, Li Q,
Liu Y, Liu M and Tian L: Co-inhibition of miRNA-21 and miRNA-221
induces apoptosis by enhancing the p53-mediated expression of
pro-apoptotic miRNAs in laryngeal squamous cell carcinoma. Mol Med
Rep. 13:4315–4320. 2016.PubMed/NCBI
|
|
33
|
Palumbo T, Faucz FR, Azevedo M, Xekouki P,
Iliopoulos D and Stratakis CA: Functional screen analysis reveals
miR-26b and miR-128 as central regulators of pituitary
somatomammotrophic tumor growth through activation of the PTEN-AKT
pathway. Oncogene. 32:1651–1659. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang XJ and Jia SS: Fisetin inhibits
laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2
signaling pathways. Biomed Pharmacother. 83:1164–1174. 2016.
View Article : Google Scholar : PubMed/NCBI
|
